5242 Nucleic Acids Research, 2011, Vol. 39, No. 12 14. Laughrea,M. and Jette,L. (1994) A 19-nucleotide sequence upstream of the 50 major splice donor is part of the dimerization domain of human immunodeﬁciency virus 1 genomic RNA. Biochemistry, 33, 13464–13474. 15. Harrison,G.P. and Lever,A.M. (1992) The human immunodeﬁciency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol., 66, 4144–4153. 16. Lever,A., Gottlinger,H., Haseltine,W. and Sodroski,J. (1989) Identiﬁcation of a sequence required for efﬁcient packaging of human immunodeﬁciency virus type 1 RNA into virions. J. Virol., 63, 4085–4087. 17. Aldovini,A. and Young,R.A. (1990) Mutations of RNA and protein sequences involved in human immunodeﬁciency virus type 1 packaging result in production of noninfectious virus. J. Virol., 64, 1920–1926. 18. Baudin,F., Marquet,R., Isel,C., Darlix,J.L., Ehresmann,B. and Ehresmann,C. (1993) Functional sites in the 50 region of human immunodeﬁciency virus type 1 RNA form deﬁned structural domains. J. Mol. Biol., 229, 382–397. 19. Clavel,F. and Orenstein,J.M. (1990) A mutant of human immunodeﬁciency virus with reduced RNA packaging and abnormal particle morphology. J. Virol., 64, 5230–5234. 20. Purcell,D.F. and Martin,M.A. (1993) Alternative splicing of human immunodeﬁciency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol., 67, 6365–6378. 21. O’Reilly,M.M., McNally,M.T. and Beemon,K.L. (1995) Two strong 50 splice sites and competing, suboptimal 30 splice sites involved in alternative splicing of human immunodeﬁciency virus type 1 RNA. Virology, 213, 373–385. 22. Abbink,T.E. and Berkhout,B. (2007) RNA structure modulates splicing efﬁciency at the HIV-1 major splice donor. J. Virol., 82, 3090–3098. 23. Damgaard,C.K., Andersen,E.S., Knudsen,B., Gorodkin,J. and Kjems,J. (2004) RNA interactions in the 50 region of the HIV-1 genome. J. Mol. Biol., 336, 369–379. 24. Abbink,T.E. and Berkhout,B. (2003) A novel long distance base-pairing interaction in human immunodeﬁciency virus type 1 RNA occludes the Gag start codon. J. Biol. Chem., 278, 11601–11611. 25. Abbink,T.E., Ooms,M., Haasnoot,P.C. and Berkhout,B. (2005) The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry, 44, 9058–9066. 26. Nikolaitchik,O., Rhodes,T.D., Ott,D. and Hu,W.-S. (2006) Effects of Mutations in the Human Immunodeﬁciency Virus Type 1 gag Gene on RNA Packaging and Recombination. J. Virol., 80, 4691–4697. 27. Song,R., Kafaie,J. and Laughrea,M. (2008) Role of the 50 TAR stem–loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA. Biochemistry, 47, 3283–3293. 28. Kozak,M. (2002) Pushing the limits of the scanning mechanism for initiation of translation. Gene, 299, 1–34. 29. Shatkin,A.J. (1976) Capping of eucaryotic mRNAs. Cell, 9, 645–653. 30. Parkin,N.T., Cohen,E.A., Darveau,A., Rosen,C., Haseltine,W. and Sonenberg,N. (1988) Mutational analysis of the 50 non-coding region of human immunodeﬁciency virus type 1: effects of secondary structure on translation. EMBO J., 7, 2831–2837. 31. Kozak,M. (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell. Biol., 9, 5134–5142. 32. Kozak,M. (1986) Inﬂuences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl Acad. Sci. USA, 83, 2850–2854. 33. Kozak,M. (1986) Point mutations deﬁne a sequence ﬂanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell, 44, 283–292. 34. Kozak,M. (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol., 196, 947–950. 35. Kozak,M. (1991) Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem., 266, 19867–19870. 36. Babendure,J.R., Babendure,J.L., Ding,J.H. and Tsien,R.Y. (2006) Control of mammalian translation by mRNA structure near caps. RNA, 12, 851–861. 37. SenGupta,D.N., Berkhout,B., Gatignol,A., Zhou,A.M. and Silverman,R.H. (1990) Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeﬁciency virus type 1. Proc. Natl Acad. Sci. USA, 87, 7492–7496. 38. Paillart,J.C., Dettenhofer,M., Yu,X.F., Ehresmann,C., Ehresmann,B. and Marquet,R. (2004) First snapshots of the HIV-1 RNA structure in infected cells and in virions. J. Biol. Chem., 279, 48397–48403. 39. Wilkinson,K.A., Gorelick,R.J., Vasa,S.M., Guex,N., Rein,A., Mathews,D.H., Giddings,M.C. and Weeks,K.M. (2008) High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol., 6, e96. 40. Watts,J.M., Dang,K.K., Gorelick,R.J., Leonard,C.W., Bess,J.W. Jr, Swanstrom,R., Burch,C.L. and Weeks,K.M. (2009) Architecture and secondary structure of an entire HIV-1 RNA genome. Nature, 460, 711–716. 41. Brasey,A., Lopez-Lastra,M., Ohlmann,T., Beerens,N., Berkhout,B., Darlix,J.L. and Sonenberg,N. (2003) The leader of human immunodeﬁciency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J. Virol., 77, 3939–3949. 42. Buck,C.B., Shen,X., Egan,M.A., Pierson,T.C., Walker,C.M. and Siliciano,R.F. (2001) The human immunodeﬁciency virus type 1 gag gene encodes an internal ribosome entry site. J. Virol., 75, 181–191. 43. Jackson,R.J. (1988) RNA translation. Picornaviruses break the rules. Nature, 334, 292–293. 44. Pelletier,J., Kaplan,G., Racaniello,V.R. and Sonenberg,N. (1988) Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 50 noncoding region. Mol. Cell. Biol., 8, 1103–1112. 45. Baird,S.D., Turcotte,M., Korneluk,R.G. and Holcik,M. (2006) Searching for IRES. RNA, 12, 1755–1785. 46. Martinez-Salas,E., Pacheco,A., Serrano,P. and Fernandez,N. (2008) New insights into internal ribosome entry site elements relevant for viral gene expression. J. Gen. Virol., 89, 611–626. 47. Jang,S.K., Krausslich,H.G., Nicklin,M.J., Duke,G.M., Palmenberg,A.C. and Wimmer,E. (1988) A segment of the 50 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol., 62, 2636–2643. 48. Spriggs,K.A., Stoneley,M., Bushell,M. and Willis,A.E. (2008) Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell, 100, 27–38. 49. Komar,A.A. and Hatzoglou,M. (2005) Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J. Biol. Chem., 280, 23425–23428. 50. Ohlmann,T., Prevot,D., Decimo,D., Roux,F., Garin,J., Morley,S.J. and Darlix,J.L. (2002) In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J. Mol. Biol., 318, 9–20. 51. Perales,C., Carrasco,L. and Ventoso,I. (2003) Cleavage of eIF4G by HIV-1 protease: effects on translation. FEBS Lett., 533, 89–94. 52. Ventoso,I., Blanco,R., Perales,C. and Carrasco,L. (2001) HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc. Natl Acad. Sci. USA, 98, 12966–12971. 53. Castello´ ,A., Franco,D., Moral-Lo´ pez,P., Berlanga,J.J., A´lvarez,E., Wimmer,E. and Carrasco,L. (2009) HIV- 1 Protease Inhibits Cap- and Poly(A)-Dependent Translation upon eIF4GI and PABP Cleavage. PLoS ONE, 4, e7997. 54. Bartz,S.R., Rogel,M.E. and Emerman,M. (1996) Human immunodeﬁciency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol., 70, 2324–2331. 55. Elder,R.T., Yu,M., Chen,M., Edelson,S. and Zhao,Y. (2000) Cell cycle G2 arrest induced by HIV-1 Vpr in ﬁssion yeast